Cerus Corp. (NASDAQ:CERS) shares were up 2.1% during trading on Monday . The company traded as high as $6.83 and last traded at $6.71, with a volume of 760,079 shares changing hands. The stock had previously closed at $6.57.

A number of research analysts have recently commented on CERS shares. BTIG Research reiterated a “buy” rating and set a $10.00 target price (up from $8.00) on shares of Cerus Corp. in a research report on Friday, April 22nd. Cantor Fitzgerald reiterated a “buy” rating and set a $9.00 target price on shares of Cerus Corp. in a research report on Thursday, July 7th. Robert W. Baird restated an “outperform” rating and set a $9.00 price target on shares of Cerus Corp. in a report on Wednesday, June 22nd. Finally, FBR & Co restated a “buy” rating on shares of Cerus Corp. in a report on Monday, May 23rd. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $8.90.

The firm has a 50 day moving average price of $6.16 and a 200-day moving average price of $5.81. The firm’s market cap is $676.37 million.

Cerus Corp. (NASDAQ:CERS) last released its quarterly earnings data on Tuesday, May 3rd. The company reported ($0.17) earnings per share for the quarter, missing the consensus estimate of ($0.16) by $0.01. The company earned $7.60 million during the quarter, compared to analysts’ expectations of $8.29 million. Cerus Corp.’s quarterly revenue was down 1.3% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.17) earnings per share. Equities research analysts expect that Cerus Corp. will post ($0.65) EPS for the current year.

A number of institutional investors have recently added to or reduced their stakes in CERS. Rail Splitter Capital Management LLC increased its position in Cerus Corp. by 19.0% in the fourth quarter. Rail Splitter Capital Management LLC now owns 832,722 shares of the company’s stock valued at $5,263,000 after buying an additional 132,970 shares during the last quarter. Stephens Inc. AR increased its position in Cerus Corp. by 11.3% in the fourth quarter. Stephens Inc. AR now owns 1,112,665 shares of the company’s stock valued at $7,032,000 after buying an additional 113,238 shares during the last quarter. Wells Fargo & Company MN increased its position in Cerus Corp. by 25.9% in the fourth quarter. Wells Fargo & Company MN now owns 4,901,666 shares of the company’s stock valued at $30,979,000 after buying an additional 1,007,430 shares during the last quarter. Finally, California State Teachers Retirement System increased its position in Cerus Corp. by 1.8% in the fourth quarter. California State Teachers Retirement System now owns 176,709 shares of the company’s stock valued at $1,117,000 after buying an additional 3,126 shares during the last quarter.

Cerus Corporation is a biomedical products company. The Company is engaged in developing and commercializing the INTERCEPT Blood System for blood safety. The Company operates through blood safety segment. The Company’s INTERCEPT Blood System is based on its technology for controlling biological replication, and is designed to reduce blood-borne pathogens in donated blood components intended for transfusion.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.